We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ERT receives Philadelphia SmartCEO’s Future 50 Award

ERT receives Philadelphia SmartCEO’s Future 50 Award

January 27, 2014
CenterWatch Staff

ERT, a global solution provider for high-quality patient safety and efficacy endpoint data collection, has announced that Philadelphia SmartCEO has recognized the company in its Future 50 Awards program. The program recognizes the region’s fastest-growing mid-sized and large Blue Chip companies that have experienced outsized growth based on a combined three-year average of revenue and employee growth. 

“We are pleased to recognize ERT for their achievements and for their contributions to moving the region forward,” said Craig Burris, founder and CEO of SmartCEO. “ERT deserves to be celebrated because they represent the future of the region’s economy and embody the innovative spirit in their industry.”

ERT delivers widely deployed solutions in centralized cardiac safety, respiratory services, suicide risk assessment and Clinical Outcome Assessments (COAs) for use in clinical development and in healthcare settings. ERT was named to the Future 50 Blue Chip category as a result of broad adoption of its solutions, which stimulated the company’s 58% revenue growth and 39% employee growth between 2010-2012.

“We are very proud to receive the Future 50 Award and to be considered one of Philadelphia’s leading companies,” said Jeffrey Litwin, M.D., CEO of ERT. “Our consistent growth reflects our employees’ commitment to delivering innovative and practical solutions that help our customers develop safe and effective medical products.”

United States Awards & Advancement

Upcoming Events

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

  • China-360x240

    U.S. Tops List of Trial Startups With China Making Progress in Phase 1

  • Phoneapp-360x240

    Device Apps Present Unique Risks in Trials

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing